Aging Demographics And Early Diagnosis Will Drive Neurology Advancement
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 13 Analysts
Published
19 Jun 25
Updated
15 Aug 25
AnalystHighTarget's Fair Value
JP¥5,870.79
19.0% undervalued intrinsic discount15 Aug
JP¥4,758.00
1Y
-19.5%7D
6.0%